Bariatric Surgery Drops 20% as GLP-1 Drugs Reshape Obesity Treatment
U.S. bariatric surgeries fell below 200,000 in 2024 while GLP-1 drugs dominate obesity care, with new findings on risks and benefits.
785 articles
U.S. bariatric surgeries fell below 200,000 in 2024 while GLP-1 drugs dominate obesity care, with new findings on risks and benefits.
A new retrospective study finds GLP-1 use in early pregnancy reduces odds of gaining too little weight, but fetal safety questions remain.
Cytokinetics' Myqorzo significantly improved symptoms and fitness in non-obstructive HCM patients, potentially expanding treatment eligibility.
A 16-week study finds creatine amplifies the anti-inflammatory and neuroplasticity benefits of fast-movement resistance training in adults over 65.
Rokit Healthcare's platform uses a patient's own fat tissue to 3D-print cartilage patches in real time, skipping lengthy lab culture steps.
A stem cell therapy for geographic atrophy showed sustained vision gains and retinal repair three years after a single injection in a Phase 1/2a trial.
Niagen Bioscience launches a clinician-directed telehealth platform delivering at-home NAD+ subcutaneous injection kits to eligible US patients.
Glycans โ sugar molecules on proteins โ shift with stress, diet, and lifestyle, and may predict disease a decade before symptoms appear.
From AI-ready drug datasets to GLP-1s as longevity drugs, 2025's biggest aging science shifts are reshaping the field.
Three major longevity industry shifts converge: open AI datasets, GLP-1 longevity drugs, and a systems-level rethink of aging science.
Arginine supplements reduced toxic amyloid buildup, brain inflammation, and behavioral decline in fly and mouse Alzheimer's models.
New research reveals creatine supports memory, mood, and cognitive speed โ not just athletic gains โ with potential for Parkinson's and depression.